Oncology News

• Tirbanibulin 1% Safe in Extensive Actinic Keratosis The safety and tolerability of tirbanibulin 1% in patients with actinic keratosis over a larger treatment field was confirmed in a phase 3 study.
  Medscape Medical News, July 26, 2024
• Which Patients With Early TNBC Can Avoid Chemotherapy? Stromal tumor-infiltrating lymphocyte levels may help determine which patients with stage I TNBC can skip chemotherapy, findings from a recent registry analysis suggested.
  Medscape Medical News, July 26, 2024
• Baseline Bone Pain Predicts Survival in Mets Prostate Cancer Baseline bone pain was associated with worse survival outcomes in patients with metastatic hormone-sensitive prostate cancer, according to a recent post hoc analysis.
  Medscape Medical News, July 25, 2024
• Skin Cancer Varies With Sexual Orientation, Study Finds Countering high lifetime skin cancer prevalence among White gay men and Black and Hispanic sexual minority men and women requires more tailored messaging.
  Medscape Medical News, July 24, 2024
• WHO Upgrades Carcinogenicity of Talc and Acrylonitrile The International Agency for Research on Cancer has reclassified talc from "possibly" to "probably" carcinogenic to humans and acrylonitrile from "possibly" carcinogenic to "carcinogenic."
  Medscape Medical News, July 24, 2024
• Alert Two Soliris Biosimilars Approved for PNH in the United States The biosimilars, Bkemv and Epysqli, are also indicated for atypical hemolytic uremic syndrome.
  Medscape Medical News, July 23, 2024
• Accelerated Approval Pathway for Cancer Drugs: Does It Work? Experts expressed concern that the accelerated pathway for cancer drug approval may be overused and does not always effectively balance access and efficacy.
  Medscape Medical News, July 23, 2024
• Hemophilia: Novel Tx Also Cuts Bleeding in Kids New research shows that efanesoctocog alfa, a bioengineered factor VIII therapy, is effective and safe in preventing bleeding in children with severe hemophilia A.
  MDedge News, July 23, 2024
• How to Manage Unresectable HCC With Liver Dysfunction A recent study published in JAMA Oncology examines the outcomes of uHCC patients with moderate liver dysfunction who are treated with immune checkpoint inhibitor therapy vs best supportive care.
  MDedge News, July 22, 2024
• Will Mesometrial Resection Become a New Standard Treatment? Total mesometrial resection shows improved recurrence-free survival and overall survival compared with standard treatment for patients with early-stage cervical cancer.
  MDedge News, July 22, 2024
• New Trials in Colorectal Cancer: Could Your Patient Benefit? Maybe one of your patients is eligible for a new colorectal cancer clinical trial?
  Medscape Medical News, July 22, 2024
• These Five AI Healthcare Tools May Be the Best Right Now We asked leading experts to share the most impactful AI tools currently in use at their hospitals.
  Medscape Medical News, July 22, 2024
• New Benzoyl Peroxide Research: Reassuring Two new studies found no increased cancer risk and no difference in blood levels of benzene in users and nonusers of BP-containing acne products.
  Medscape Medical News, July 22, 2024
• Could an EHR Nudge Reduce Unnecessary Biopsies? A nudge intervention using electronic health records could help decrease the number of unnecessary sentinel lymph node biopsies in older women with early-stage breast cancer.
  MDedge News, July 19, 2024
• PSMA PET-CT Provides Staging Benefits Over MRI A new study shows that 18F-PSMA-1007 PET-CT provided significant locoregional staging benefits over MRI in patients with prostate cancer undergoing surgery.
  Medscape Medical News, July 19, 2024
• 'Chemoresistance Can Be Reversed': Toughest Cancers Targeted Targeting the tissue around tumors may reduce drug resistance for hard-to-treat cancers like pancreatic cancer, according to Stanford researchers.
  Medscape Medical News, July 18, 2024
• ASCO 2024 DLBCL: Tucidinostat Plus R-CHOP Improves Outcomes? In previously untreated "double-expresser" patients, combining tucidinostat with standard R-CHOP chemotherapy resulted in better complete response and event-free survival rates than R-CHOP alone.
  MDedge News, July 18, 2024
• Beauty Bloggers Dominate TikTok's Sun Protection Content Beauty bloggers and consumers contributed to most of the content discussing sun protection and skin cancer on TikTok.
  Medscape Medical News, July 18, 2024
• This Cancer Screening Approach Is Unreliable in Black Women Transvaginal ultrasound used to evaluate the need for endometrial cancer biopsy has high error rate in high-risk Black women, suggesting a need for alternative diagnostic strategies.
  Medscape Medical News, July 17, 2024
• FDG-PET/CT Reduces Unnecessary Surgery in Head, Neck Cancer FDG-PET/CT imaging performed 3 months after chemoradiation for head and neck squamous cell carcinoma spares many patients from a salvage neck dissection, new data indicate.
  Medscape Medical News, July 17, 2024